Skip to main content
Signal8

STARR CHRISTOPHER M

SEC insider (Form 3/4/5 filer). CIK 0001235470. Director at Monopar Therapeutics (MNPR). 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WILMETTE, IL.

Companies STARR CHRISTOPHER M has filed insider reports for

  • Monopar Therapeutics (MNPR): Director
STARR CHRISTOPHER M profile photo

STARR CHRISTOPHER M

CIK: 0001235470

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Oct 1, 2026
    Sale
    Direct
    799 shares at avg. $79.67$64K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Oct 1, 2026
    Exercise
    Direct
    8.4K shares at avg. $0.01$42
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Oct 1, 2026
    Sale
    Direct
    4.6K shares at avg. $78.09$362K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Oct 1, 2026
    Sale
    Direct
    3K shares at avg. $78.82$234K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 2, 2025
    Award

    Stock Options

    Direct
    2.9K shares-
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Jul 14, 2025
    In-the-Money
    Direct
    16.8K shares at avg. $0.01$84
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Jul 14, 2025
    Sale
    Direct
    16.8K shares at avg. $40.00$672K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Mar 4, 2025
    Award

    Stock Options

    Direct
    11.4K shares-

1-8 of 8